| Year |
Citation |
Score |
| 2024 |
Ng HS, Zhu F, Zhao Y, Yao S, Lu X, Ekuma O, Evans C, Fisk JD, Marrie RA, Tremlett H. Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis. Neurology. 102: e208006. PMID 38181306 DOI: 10.1212/WNL.0000000000208006 |
0.324 |
|
| 2023 |
Yusuf FLA, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Gastrointestinal conditions in the multiple sclerosis prodrome. Annals of Clinical and Translational Neurology. PMID 38115680 DOI: 10.1002/acn3.51945 |
0.363 |
|
| 2023 |
Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JMA, Evans C, Fisk JD, Marrie RA, Tremlett H. Multiple sclerosis disease-modifying drug use by immigrants: a real-world study. Scientific Reports. 13: 21235. PMID 38040796 DOI: 10.1038/s41598-023-46313-7 |
0.386 |
|
| 2023 |
Chertcoff AS, Yusuf F, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis. Neurology. PMID 37748884 DOI: 10.1212/WNL.0000000000207843 |
0.343 |
|
| 2022 |
Chertcoff A, Ng HS, Zhu F, Zhao Y, Tremlett H. Polypharmacy and multiple sclerosis: A population-based study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221122207. PMID 36301629 DOI: 10.1177/13524585221122207 |
0.388 |
|
| 2022 |
Marrie RA, Allegretta M, Barcellos LF, Bebo B, Calabresi PA, Correale J, Davis B, De Jager PL, Gasperi C, Greenbaum C, Helme A, Hemmer B, Kanellis P, Kostich W, Landsman D, ... ... Zhao Y, et al. From the prodromal stage of multiple sclerosis to disease prevention. Nature Reviews. Neurology. PMID 35840705 DOI: 10.1038/s41582-022-00686-x |
0.332 |
|
| 2022 |
Ng HS, Zhu F, Kingwell E, Yao S, Ekuma O, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35701187 DOI: 10.1212/NXI.0000000000200005 |
0.315 |
|
| 2022 |
Liang G, Zhu F, Mirza AI, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, Marrie RA, O'Mahony J, Van Domselaar G, Yeh EA, Zhao Y, et al. Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221079533. PMID 35296164 DOI: 10.1177/13524585221079533 |
0.344 |
|
| 2021 |
Ng HS, Graf J, Zhu F, Kingwell E, Aktas O, Albrecht P, Hartung HP, Meuth SG, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population. Frontiers in Immunology. 12: 794075. PMID 35095869 DOI: 10.3389/fimmu.2021.794075 |
0.312 |
|
| 2021 |
Mirza AI, Zhu F, Knox N, Forbes JD, Van Domselaar G, Bernstein CN, Graham M, Marrie RA, Hart J, Yeh EA, Arnold D, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, et al. Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome. Neurology. PMID 34937787 DOI: 10.1212/WNL.0000000000013245 |
0.371 |
|
| 2021 |
Tremlett H, Zhu F, Arnold D, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, Marrie RA, Mirza AI, O'Mahony J, Van Domselaar G, Yeh EA, ... Zhao Y, et al. The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. Annals of Clinical and Translational Neurology. 8: 2252-2269. PMID 34889081 DOI: 10.1002/acn3.51476 |
0.358 |
|
| 2020 |
Ng HS, Zhu F, Kingwell E, Zhao Y, Yao S, Ekuma O, Svenson LW, Evans C, Fisk JD, Marrie RA, Tremlett H. Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting. Expert Review of Neurotherapeutics. PMID 33146570 DOI: 10.1080/14737175.2021.1847085 |
0.324 |
|
| 2020 |
Yusuf F, Wijnands JM, Kingwell E, Zhu F, Evans C, Fisk JD, Zhao Y, Sutherland JM, Patrick DM, Marrie RA, Tremlett H. Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520908163. PMID 32250183 DOI: 10.1177/1352458520908163 |
0.391 |
|
| 2020 |
Zhao Y, Wijnands JMA, Högg T, Kingwell E, Zhu F, Evans C, Fisk JD, Marrie RA, Tremlett H. Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health Data. Neuroepidemiology. 1-8. PMID 31940638 DOI: 10.1159/000505331 |
0.467 |
|
| 2019 |
Marrie RA, Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Tremlett H. Higher health care use before a clinically isolated syndrome with or without subsequent MS. Multiple Sclerosis and Related Disorders. 35: 42-49. PMID 31319354 DOI: 10.1016/J.Msard.2019.07.002 |
0.433 |
|
| 2019 |
Högg T, Zhao Y, Gustafson P, Petkau J, Fisk J, Marrie RA, Tremlett H. Adjusting for differential misclassification in matched case-control studies utilizing health administrative data. Statistics in Medicine. PMID 31115088 DOI: 10.1002/Sim.8203 |
0.391 |
|
| 2019 |
Wijnands JMA, Zhu F, Kingwell E, Zhao Y, Evans C, Fisk JD, Marrie RA, Tremlett H. The prodrome in relapsing remitting and primary progressive multiple sclerosis. European Journal of Neurology. PMID 30714270 DOI: 10.1111/Ene.13925 |
0.42 |
|
| 2018 |
Wijnands JMA, Ekuma O, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Tremlett H, Marrie RA. MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis. Multiple Sclerosis and Related Disorders. 28: 138-144. PMID 30594814 DOI: 10.1016/J.Msard.2018.12.030 |
0.431 |
|
| 2018 |
Vertinsky AT, Li DKB, Vavasour IM, Miropolsky V, Zhao G, Zhao Y, Riddehough A, Moore GRW, Traboulsee A, Laule C. Diffusely Abnormal White Matter, T Burden of Disease, and Brain Volume in Relapsing-Remitting Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30376195 DOI: 10.1111/Jon.12574 |
0.442 |
|
| 2018 |
Marrie RA, Ekuma O, Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Tremlett H. Identifying optic neuritis and transverse myelitis using administrative data. Multiple Sclerosis and Related Disorders. 25: 258-264. PMID 30144696 DOI: 10.1016/J.Msard.2018.08.013 |
0.377 |
|
| 2018 |
Högg T, Wijnands JMA, Kingwell E, Zhu F, Lu X, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Mining healthcare data for markers of the multiple sclerosis prodrome. Multiple Sclerosis and Related Disorders. 25: 232-240. PMID 30121490 DOI: 10.1016/J.Msard.2018.08.007 |
0.467 |
|
| 2018 |
Wijnands JM, Zhu F, Kingwell E, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H. Five years before multiple sclerosis onset: Phenotyping the prodrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518783662. PMID 29979093 DOI: 10.1177/1352458518783662 |
0.491 |
|
| 2018 |
Wijnands JMA, Zhu F, Kingwell E, Fisk JD, Evans C, Marrie RA, Zhao Y, Tremlett H. Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29602795 DOI: 10.1136/Jnnp-2017-317493 |
0.379 |
|
| 2017 |
Högg T, Petkau J, Zhao Y, Gustafson P, Wijnands JM, Tremlett H. Bayesian analysis of pair-matched case-control studies subject to outcome misclassification. Statistics in Medicine. PMID 28783882 DOI: 10.1002/Sim.7427 |
0.327 |
|
| 2017 |
Sadovnick AD, Traboulsee AL, Zhao Y, Bernales CQ, Encarnacion M, Ross JP, Yee IM, Criscuoli MG, Vilariño-Güell C. Genetic modifiers of multiple sclerosis progression, severity and onset. Clinical Immunology (Orlando, Fla.). 180: 100-105. PMID 28501589 DOI: 10.1016/J.Clim.2017.05.009 |
0.416 |
|
| 2017 |
Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Högg T, Stadnyk K, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. The Lancet. Neurology. PMID 28434855 DOI: 10.1016/S1474-4422(17)30076-5 |
0.359 |
|
| 2017 |
Evans C, Marrie RA, Zhu F, Leung S, Lu X, Kingwell E, Zhao Y, Tremlett H. Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations. Pharmacoepidemiology and Drug Safety. PMID 28370875 DOI: 10.1002/Pds.4207 |
0.389 |
|
| 2017 |
Tremlett H, Zhao Y. Primary and secondary progressive MS have a similar age at onset of progression - NO. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 640-642. PMID 28357927 DOI: 10.1177/1352458516684559 |
0.427 |
|
| 2017 |
Kondo Y, Zhao Y, Petkau J. Identification of treatment responders based on multiple longitudinal outcomes with applications to multiple sclerosis patients. Statistics in Medicine. PMID 28147439 DOI: 10.1002/Sim.7230 |
0.364 |
|
| 2016 |
Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Marrie RA, Tremlett H. Infection-related health care utilization among people with and without multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458516681198. PMID 28273769 DOI: 10.1177/1352458516681198 |
0.398 |
|
| 2016 |
Martin N, Traboulsee AL, Machan L, Klass D, Ellchuk T, Zhao Y, Knox KB, Kopriva D, Lala S, Nickel D, Otani R, Perera WR, Rauscher A, Sadovnick AD, Szkup P, et al. Prevalence of Extracranial Venous Narrowing on Magnetic Resonance Venography is Similar in People With Multiple Sclerosis, Their Siblings, and Unrelated Healthy Controls: A Blinded, Case-Control Study. Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes. PMID 27887935 DOI: 10.1016/J.Carj.2016.07.002 |
0.322 |
|
| 2016 |
Evans C, Marrie RA, Zhu F, Leung S, Lu X, Melesse DY, Kingwell E, Zhao Y, Tremlett H. Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Multiple Sclerosis and Related Disorders. 8: 78-85. PMID 27456879 DOI: 10.1016/J.Msard.2016.05.006 |
0.424 |
|
| 2016 |
Manogaran P, Vavasour IM, Lange AP, Zhao Y, McMullen K, Rauscher A, Carruthers R, Li DK, Traboulsee AL, Kolind SH. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica. Neuroimage. Clinical. 11: 743-50. PMID 27330974 DOI: 10.1016/J.Nicl.2016.05.014 |
0.303 |
|
| 2016 |
Zhang T, Kingwell E, De Jong HJ, Zhu F, Zhao Y, Carruthers R, Petkau J, Gustafson P, Oger J, Tremlett H. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Pharmacoepidemiology and Drug Safety. PMID 27211481 DOI: 10.1002/Pds.4031 |
0.457 |
|
| 2016 |
Evans C, Marrie RA, Zhu F, Leung S, Lu X, Melesse DY, Kingwell E, Zhao Y, Tremlett H. Adherence and persistence to drug therapies for multiple sclerosis: A population-based study Multiple Sclerosis and Related Disorders. 8: 78-85. DOI: 10.1016/j.msard.2016.05.006 |
0.33 |
|
| 2015 |
Zhao Y, Kondo Y, Traboulsee A, Li DK, Riddehough A, Petkau AJ. Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315577829. PMID 28607690 DOI: 10.1177/2055217315577829 |
0.32 |
|
| 2015 |
Hernández-Torres E, Wiggermann V, Hametner S, Baumeister TR, Sadovnick AD, Zhao Y, Machan L, Li DK, Traboulsee A, Rauscher A. Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls. Plos One. 10: e0140956. PMID 26489078 DOI: 10.1371/Journal.Pone.0140956 |
0.386 |
|
| 2015 |
MacMillan EL, Tam R, Zhao Y, Vavasour IM, Li D, Oger J, Freedman MS, Kolind SH, Traboulsee AL. Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26014604 DOI: 10.1177/1352458515586086 |
0.361 |
|
| 2015 |
Shirani A, Zhao Y, Petkau J, Gustafson P, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Tremlett H. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment. Biomed Research International. 2015: 451912. PMID 25922836 DOI: 10.1155/2015/451912 |
0.403 |
|
| 2015 |
Zhang T, Shirani A, Zhao Y, Karim ME, Gustafson P, Petkau J, Evans C, Kingwell E, van der Kop M, Zhu F, Oger J, Tremlett H. Beta-interferon exposure and onset of secondary progressive multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 990-1000. PMID 25846809 DOI: 10.1111/Ene.12698 |
0.472 |
|
| 2015 |
Kondo Y, Zhao Y, Petkau J. A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients. Statistics in Medicine. 34: 2165-80. PMID 25784219 DOI: 10.1002/Sim.6484 |
0.383 |
|
| 2015 |
Dong J, Zhao Y, Petkau AJ, Li DK, Riddehough A, Traboulsee A. Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 101-4. PMID 24852923 DOI: 10.1177/1352458514533846 |
0.407 |
|
| 2014 |
Evans C, Zhu F, Kingwell E, Shirani A, van der Kop ML, Petkau J, Gustafson P, Zhao Y, Oger J, Tremlett H. Association between beta-interferon exposure and hospital events in multiple sclerosis. Pharmacoepidemiology and Drug Safety. 23: 1213-22. PMID 24953054 DOI: 10.1002/Pds.3667 |
0.355 |
|
| 2014 |
Karim ME, Gustafson P, Petkau J, Zhao Y, Shirani A, Kingwell E, Evans C, van der Kop M, Oger J, Tremlett H. Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort. American Journal of Epidemiology. 180: 160-71. PMID 24939980 DOI: 10.1093/Aje/Kwu125 |
0.454 |
|
| 2014 |
Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L, Sadovnick AD, Traboulsee A, Tremlett H. Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs. Cns Drugs. 28: 475-82. PMID 24643915 DOI: 10.1007/S40263-014-0154-6 |
0.437 |
|
| 2014 |
Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick AD, Synnes A, Dahlgren L, Traboulsee A, Tremlett H. Birth outcomes of pregnancies fathered by men with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1260-4. PMID 24500603 DOI: 10.1177/1352458514521308 |
0.472 |
|
| 2014 |
Shirani A, Zhao Y, Karim ME, Petkau J, Gustafson P, Evans C, Kingwell E, van der Kop ML, Oger J, Tremlett H. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 21: 835-44. PMID 24351059 DOI: 10.1111/Ene.12324 |
0.373 |
|
| 2014 |
Traboulsee AL, Knox KB, Machan L, Zhao Y, Yee I, Rauscher A, Klass D, Szkup P, Otani R, Kopriva D, Lala S, Li DK, Sadovnick D. Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study. Lancet (London, England). 383: 138-45. PMID 24119384 DOI: 10.1016/S0140-6736(13)61747-X |
0.414 |
|
| 2014 |
Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y, Zhao Y, Li DKB. Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes Multiple Sclerosis Journal. 20: 458-463. PMID 23970502 DOI: 10.1177/1352458513501230 |
0.448 |
|
| 2014 |
Zhao Y, Li DKB, Petkau AJ, Riddehough A, Traboulsee A. Detection of Unusual Increases in MRI Lesion Counts in Individual Multiple Sclerosis Patients Journal of the American Statistical Association. 109: 119-132. DOI: 10.1080/01621459.2013.847373 |
0.371 |
|
| 2013 |
Lu E, Zhao Y, Dahlgren L, Preston R, van der Kop M, Synnes A, Sadovnick AD, Traboulsee A, Tremlett H. Obstetrical epidural and spinal anesthesia in multiple sclerosis. Journal of Neurology. 260: 2620-8. PMID 23864398 DOI: 10.1007/S00415-013-7035-7 |
0.442 |
|
| 2013 |
Menon S, Shirani A, Zhao Y, Oger J, Traboulsee A, Freedman MS, Tremlett H. Characterising aggressive multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1192-8. PMID 23744892 DOI: 10.1136/Jnnp-2013-304951 |
0.486 |
|
| 2013 |
Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H. Interferon beta and long-term disability in multiple sclerosis. Jama Neurology. 70: 651-2. PMID 23699948 DOI: 10.1001/Jamaneurol.2013.2197 |
0.325 |
|
| 2013 |
Riddell CA, Zhao Y, Petkau J. An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context. Statistical Methods in Medical Research. PMID 23592713 DOI: 10.1177/0962280213480576 |
0.419 |
|
| 2013 |
Lu E, Zhao Y, Zhu F, van der Kop ML, Synnes A, Dahlgren L, Sadovnick AD, Sayao AL, Tremlett H. Birth hospitalization in mothers with multiple sclerosis and their newborns. Neurology. 80: 447-52. PMID 23303853 DOI: 10.1212/Wnl.0B013E31827F0Efc |
0.434 |
|
| 2013 |
Lu E, Zhu F, Zhao Y, Kop Mvd, Synnes A, Dahlgren L, Sadovnick AD, Traboulsee A, Tremlett H. Birth outcomes of pregnancies fathered by men with multiple sclerosis Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1385 |
0.326 |
|
| 2012 |
Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. Jama. 308: 247-56. PMID 22797642 DOI: 10.1001/Jama.2012.7625 |
0.445 |
|
| 2012 |
Tremlett H, Zhu F, Petkau J, Oger J, Zhao Y. Natural, innate improvements in multiple sclerosis disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1412-21. PMID 22736751 DOI: 10.1177/1352458512439119 |
0.448 |
|
| 2012 |
Martin N, Malfair D, Zhao Y, Li D, Traboulsee A, Lang D, Vertinsky AT. Comparison of MERGE and axial T2-weighted fast spin-echo sequences for detection of multiple sclerosis lesions in the cervical spinal cord. Ajr. American Journal of Roentgenology. 199: 157-62. PMID 22733907 DOI: 10.2214/Ajr.11.7039 |
0.355 |
|
| 2012 |
Shirani A, Zhao Y, Kingwell E, Rieckmann P, Tremlett H. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009). Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 442-50. PMID 21952097 DOI: 10.1177/1352458511422097 |
0.488 |
|
| 2012 |
Kingwell E, Kop Mvd, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada Journal of Neurology, Neurosurgery, and Psychiatry. 83: 61-66. PMID 21865212 DOI: 10.1136/Jnnp-2011-300616 |
0.403 |
|
| 2011 |
Riddell CA, Zhao Y, Li DKB, Petkau AJ, Riddehough A, Cutter GR, Traboulsee A. Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis Neurology. 77: 2089-2096. PMID 22094474 DOI: 10.1212/Wnl.0B013E31823D762D |
0.407 |
|
| 2011 |
Zhang Y, Traboulsee A, Zhao Y, Metz LM, Li DK. Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: a preliminary study. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 532-40. PMID 21270058 DOI: 10.1177/1352458510395981 |
0.377 |
|
| 2010 |
Laule C, Vavasour IM, Zhao Y, Traboulsee AL, Oger J, Vavasour JD, Mackay AL, Li DKB. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis Multiple Sclerosis Journal. 16: 670-677. PMID 20558500 DOI: 10.1177/1352458510365586 |
0.37 |
|
| 2010 |
Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology. 74: 2004-15. PMID 20548045 DOI: 10.1212/Wnl.0B013E3181E3973F |
0.481 |
|
| 2010 |
Koch M, Zhao Y, Yee I, Guimond C, Kingwell E, Rieckmann P, Sadovnick D, Tremlett H, Neurologists UMC. Disease onset in familial and sporadic primary progressive multiple sclerosis Multiple Sclerosis Journal. 16: 694-700. PMID 20378663 DOI: 10.1177/1352458510367661 |
0.391 |
|
| 2010 |
Zhao Y, Petkau AJ, Traboulsee A, Riddehough A, Li DKB. Does MRI lesion activity regress in secondary progressive multiple sclerosis Multiple Sclerosis Journal. 16: 434-442. PMID 20167592 DOI: 10.1177/1352458509359726 |
0.392 |
|
| 2009 |
Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y. Impact of multiple sclerosis relapses on progression diminishes with time Neurology. 73: 1616-1623. PMID 19890070 DOI: 10.1212/Wnl.0B013E3181C1E44F |
0.413 |
|
| 2009 |
Tremlett H, Zhao Y, Devonshire V. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. Journal of Neurology. 256: 374-81. PMID 19308306 DOI: 10.1007/S00415-009-0039-7 |
0.421 |
|
| 2009 |
Zhao GJ, Traboulsee A, Li D, Riddehough A, Zhao Y, Cheng Y. PO10-TU-19 Can changes of the third ventricular width on MRI demonstrate treatment effect in patients with multiple sclerosis? Journal of the Neurological Sciences. 285. DOI: 10.1016/S0022-510X(09)70768-3 |
0.376 |
|
| 2009 |
Zhao Y, Petkau AJ, Traboulsee A, Riddehough A, Li D. FP14-TU-05 Regression of new gadolinium-enhancing lesion activity related to pre-study relapses in secondary progressive multiple sclerosis Journal of the Neurological Sciences. 285. DOI: 10.1016/S0022-510X(09)70339-9 |
0.392 |
|
| 2008 |
Tremlett H, Zhao Y, Devonshire V. Defining the natural history of MS: the need for complete data and rigorous definitions. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1142-3; author reply. PMID 18701573 DOI: 10.1177/1352458508095131 |
0.449 |
|
| 2008 |
Tremlett H, Zhao Y, Joseph J, Devonshire V, Adams D, Craig D, Daly L, Hashimoto S, Hiebiceck O, Hooge J, Jones B, Kastrukoff L, Meckling S, Oger J, Parton D, et al. Relapses in multiple sclerosis are age- and time-dependent Journal of Neurology, Neurosurgery and Psychiatry. 79: 1368-1374. PMID 18535026 DOI: 10.1136/Jnnp.2008.145805 |
0.446 |
|
| 2008 |
Zhao Y, Traboulsee A, Petkau AJ, Li D. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis. Neurology. 70: 1092-7. PMID 18003938 DOI: 10.1212/01.Wnl.0000285426.73143.F7 |
0.447 |
|
| 2008 |
Zhao Y, Joe H. Inferences for odds ratio with dependent pairs Test. 17: 101-119. DOI: 10.1007/S11749-006-0025-7 |
0.513 |
|
| 2005 |
Zhao Y, Joe H. Composite likelihood estimation in multivariate data analysis Canadian Journal of Statistics. 33: 335-356. DOI: 10.1002/Cjs.5540330303 |
0.505 |
|
| 2002 |
Zhao Y, Kumar RA, Baser ME, Evans DG, Wallace A, Kluwe L, Mautner VF, Parry DM, Rouleau GA, Joe H, Friedman JM. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2). Genetic Epidemiology. 23: 245-59. PMID 12384977 DOI: 10.1002/Gepi.10181 |
0.529 |
|
| Show low-probability matches. |